PMA

P210039: Chocolate Touch Paclitaxel Drug-Coated PTA Balloon Catheter (Chocolate Touch)

FDA PMA · Drug-Eluting Peripheral Transluminal Angioplasty Catheter · Trireme Medical, LLC

Key facts

PMA number P210039
Trade name Chocolate Touch Paclitaxel Drug-Coated PTA Balloon Catheter (Chocolate Touch)
Generic name Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Applicant Trireme Medical, LLC
Product code ONU
Approval date Nov 4, 2022
Docket number 22M-2824
Notice date Nov 18, 2022
FEI number 3008089360

At a glance

  • 1–9 Supplements
  • Aug 16, 2023 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals